Overexpression of EGFR is related to survival, invasion, metastasis, drug resistance, and poor prognosis of tumor [58], for example, EGFR is considered as an indicator of inferior prognosis in node-negative breast cancer [59]. The gene discussed is EGFR; the disease is neoplasm.